Search research articles
Contact Us
Filters
Showing results (51-60 of 109) with videos related to
Page
of 11
Sort By:
American Journal of Clinical Pathology
|
June 19, 2012
Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay
Shalini Verma, Wesley O Greaves, Farhad Ravandi, et al.
American Journal of Clinical Pathology
|
July 18, 2015
B-Lymphoblastic Leukemia in Patients With Chronic Lymphocytic Leukemia: A Report of Four Cases
Zaher Chakhachiro, C Cameron Yin, Lynne V Abruzzo, et al.
Blood
|
November 3, 2010
Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML
Bing Z Carter, Yi Hua Qiu, Nianxiang Zhang, et al.
Cancer
|
February 28, 2007
Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia
Ahmed Aribi, Hagop M Kantarjian, Elihu H Estey, et al.
Blood
|
May 3, 2002
Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase
Hagop M Kantarjian, Jorge Cortes, Susan O'Brien, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 13, 2004
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial
Edwin DeJesus, Debra McCarty, Charles F Farthing, et al.
Cancer
|
March 26, 2004
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia
Francis J Giles, Martin S Tallman, Guillermo Garcia-Manero, et al.
Cancer
|
August 27, 2009
Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia
Deborah A Thomas, Hagop M Kantarjian, Wendy Stock, et al.
Cancer
|
April 12, 2011
Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial
Ruben A Mesa, Hagop Kantarjian, Ayalew Tefferi, et al.
British Journal of Haematology
|
October 3, 2002
Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival
Francis J Giles, Hagop M Kantarjian, B Nebiyou Bekele, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 109) with videos related to
Sort By:
Page
of 11
American Journal of Clinical Pathology
|
June 19, 2012
Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay
Shalini Verma, Wesley O Greaves, Farhad Ravandi, et al.
American Journal of Clinical Pathology
|
July 18, 2015
B-Lymphoblastic Leukemia in Patients With Chronic Lymphocytic Leukemia: A Report of Four Cases
Zaher Chakhachiro, C Cameron Yin, Lynne V Abruzzo, et al.
Blood
|
November 3, 2010
Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML
Bing Z Carter, Yi Hua Qiu, Nianxiang Zhang, et al.
Cancer
|
February 28, 2007
Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia
Ahmed Aribi, Hagop M Kantarjian, Elihu H Estey, et al.
Blood
|
May 3, 2002
Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase
Hagop M Kantarjian, Jorge Cortes, Susan O'Brien, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 13, 2004
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial
Edwin DeJesus, Debra McCarty, Charles F Farthing, et al.
Cancer
|
March 26, 2004
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia
Francis J Giles, Martin S Tallman, Guillermo Garcia-Manero, et al.
Cancer
|
August 27, 2009
Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia
Deborah A Thomas, Hagop M Kantarjian, Wendy Stock, et al.
Cancer
|
April 12, 2011
Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial
Ruben A Mesa, Hagop Kantarjian, Ayalew Tefferi, et al.
British Journal of Haematology
|
October 3, 2002
Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival
Francis J Giles, Hagop M Kantarjian, B Nebiyou Bekele, et al.
Page
of 11